Molecular network regulation and precision therapy frontiers in osteoarthritis: from ferroptosis to autophagy metabolic reprogramming
Journal of Biomed Research · 14.02.2026 · 7 (1) · 13
DOI: 10.46439/biomedres.7.077 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Biomed Research, online erschienen am 14.02.2026. Verfasst von Yue Zhang und 5 weiteren Autor:innen. Die Arbeit nennt 44 Literaturangaben.
Abstract (Originalsprache)
Osteoarthritis (OA), the most prevalent degenerative joint disease, involves intricate molecular interactions across joint tissues. This review highlights advancements in understanding OA pathogenesis, focusing on the ferroptosis-autophagy axis and the therapeutic potential of Coenzyme Q10 (CoQ10). By integrating and reviewing multi-omics technologies, novel diagnostic tools, and targeted therapies, this review underscores the shift toward precision medicine in OA management.
Zitieren
APA
Zhang, Y., Zhang, H., Zhu, X., Gao, B., Meguellati, K., & Huang, C. (2026). Molecular network regulation and precision therapy frontiers in osteoarthritis: from ferroptosis to autophagy metabolic reprogramming. Journal of Biomed Research, 7(1), 13. https://doi.org/10.46439/biomedres.7.077
Vancouver
Zhang Y, Zhang H, Zhu X, Gao B, Meguellati K, Huang C. Molecular network regulation and precision therapy frontiers in osteoarthritis: from ferroptosis to autophagy metabolic reprogramming. Journal of Biomed Research. 2026;7(1):13. doi:10.46439/biomedres.7.077
BibTeX
@article{Zhang2026,
author = {Zhang, Yue and Zhang, Huichang and Zhu, Xiaoying and Gao, Bohong and Meguellati, Kamel and Huang, Cibo},
title = {Molecular network regulation and precision therapy frontiers in osteoarthritis: from ferroptosis to autophagy metabolic reprogramming},
journal = {Journal of Biomed Research},
year = {2026},
volume = {7},
number = {1},
pages = {13},
doi = {10.46439/biomedres.7.077}
}
EUVIMED